Overview

Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess local nasal adverse effects, as well as systemic effects, of PATANASE nasal spray when compared with Patanase Vehicle, pH 3.7 and Patanase Vehicle, pH 7.0 in patients with perennial allergic rhinitis (PAR).
Phase:
Phase 4
Details
Lead Sponsor:
Alcon Research
Treatments:
Olopatadine Hydrochloride